Management of AUB in a 46-Year-Old with Mildly Elevated Prolactin and Low AMH
This 46-year-old perimenopausal woman requires immediate structural evaluation with transvaginal ultrasound, endometrial assessment given her age and bleeding pattern, and treatment of the hyperprolactinemia as a contributing cause of ovulatory dysfunction. 1
Initial Diagnostic Workup
Mandatory Immediate Assessments
- Pregnancy test (β-hCG) must be performed despite perimenopausal status 1
- Hemodynamic stability assessment—urgent evaluation needed if saturating a large pad hourly for ≥4 hours 1
- Complete blood count to assess for anemia, which affects 20% of women with AUB 2, 3
- Speculum examination to exclude cervical or vaginal bleeding sources 1
- Bimanual examination to assess uterine size, contour, and adnexal masses 1
Laboratory Evaluation Already Completed
- The prolactin level of 32 ng/mL represents mild hyperprolactinemia and confirms ovulatory dysfunction as a contributing mechanism 1, 2
- TSH should be checked if not already done, as thyroid dysfunction causes both anovulatory and ovulatory AUB 1, 2
- The AMH of 2.415 ng/mL indicates diminished ovarian reserve consistent with perimenopausal transition, which increases anovulation risk 4
Imaging Strategy
First-Line Imaging
- Combined transabdominal and transvaginal ultrasound with Doppler is the most appropriate initial imaging study 5, 1
- Transvaginal approach provides superior endometrial and myometrial assessment 1
- Transabdominal imaging assesses enlarged uterus or masses beyond transvaginal field of view 5
- Doppler evaluation identifies vascularity within endometrial polyps or cancer 5
Second-Line Imaging if Initial Ultrasound Unclear
- Saline infusion sonohysterography (SIS) should be performed if initial ultrasound shows focal endometrial abnormality or thickened endometrium 5, 1
- SIS distinguishes leiomyomas from endometrial polyps with 97% accuracy 5, 1
- SIS has 96-100% sensitivity and 94-100% negative predictive value for uterine pathology 1
Endometrial Sampling Indications
At age 46 with AUB, this patient requires endometrial biopsy given her perimenopausal status and risk stratification. 1, 6
Specific Indications Present
- Age ≥35 years with recurrent anovulation (confirmed by hyperprolactinemia) 2
- Perimenopausal status with AUB warrants endometrial assessment 1, 6
- Additional risk factors requiring biopsy include obesity, diabetes, hypertension, or unopposed estrogen exposure if present 1
Optimal Biopsy Technique
- Office hysteroscopy with directed biopsy is the gold standard approach, especially for high-risk perimenopausal women 6
- Blind endometrial biopsies should no longer be performed as sole diagnostic strategy in perimenopausal women 6
- Single-stop approach combining office hysteroscopy, directed biopsy of focal lesions, and vacuum sampling of normal-appearing endometrium provides most accurate diagnosis 6
Treatment of Hyperprolactinemia
The prolactin level of 32 ng/mL requires further evaluation and treatment as it contributes to ovulatory dysfunction causing AUB. 1, 2
- Investigate secondary causes: medication review (antipsychotics, antiepileptics), thyroid dysfunction, pituitary adenoma 2
- MRI of pituitary if prolactin remains elevated without medication cause
- Dopamine agonist therapy (cabergoline or bromocriptine) if prolactinoma or idiopathic hyperprolactinemia confirmed
- Correcting hyperprolactinemia may restore ovulatory cycles and reduce bleeding 2
Medical Management Options
First-Line Medical Therapy (After Excluding Malignancy)
Levonorgestrel-releasing intrauterine system (LNG-IUS) is the most effective first-line treatment for idiopathic AUB in perimenopausal women. 2, 3, 7
Alternative Medical Options (Ranked by Efficacy)
- Tranexamic acid—particularly useful if hormones contraindicated or immediate pregnancy desired 2, 3
- Combined oral contraceptives—regulate menstrual cycles and treat anovulatory bleeding 2, 3, 7
- Cyclic progestins (21 days per month)—effective for anovulatory bleeding 2, 3
- NSAIDs—reduce menstrual blood loss by 20-50% 2, 3
Perimenopausal-Specific Consideration
- Pulsatile courses of selective progesterone receptor modulators (ulipristal acetate where available) can bridge perimenopausal women to menopause while avoiding surgery 5
- This approach particularly useful for women nearing menopause who wish to avoid hysterectomy 5
Surgical Management
Indications for Surgical Intervention
- Failed medical management after 3-6 months 1, 3
- Structural lesions identified (polyps, submucosal fibroids) requiring removal 1, 3
- Patient preference after counseling on options 3
Surgical Options (Ranked by Invasiveness)
- Hysteroscopic polypectomy or myomectomy for focal lesions 5, 3
- Second-generation endometrial ablation (thermal balloon, microwave, radiofrequency) for completed childbearing 3
- Hysterectomy (vaginal or laparoscopic route preferred)—most definitive but reserved for failed conservative measures 2, 3
Critical Pitfalls to Avoid
- Do not skip pregnancy testing despite perimenopausal status and low AMH 1
- Do not perform blind endometrial biopsy alone in perimenopausal women—combine with imaging or hysteroscopy 6
- Do not attribute all bleeding to anovulation without excluding structural causes (polyps, adenomyosis, leiomyomas, malignancy) 4, 1
- Do not overlook hyperprolactinemia as a treatable cause requiring specific workup 1, 2
- Do not proceed to hysterectomy without attempting medical management or conservative surgical options first 3
Referral Criteria
Refer to gynecology if: